Apellis Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 1,681 | 0.0% | 66,916 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 1,941 | 0.0% | 85,761 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 1,634 | 0.0% | 94,404 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,851 | 0.0% | 84,615 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 2,565 | 0.0% | 80,382 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 2,337 | 0.0% | 81,039 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 2,967 | 0.0% | 77,349 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 3,037 | 0.0% | 51,675 | 3/31/2024 |
| 2023 Q4 | 2/12/2024 | 4,059 | 0.0% | 67,805 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 3,149 | 0.0% | 82,772 | 9/30/2023 |
| 2023 Q2 | 8/14/2023 | 6,998 | 0.0% | 76,820 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 5,381 | 0.0% | 81,584 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 4,559 | 0.0% | 88,158 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 5,545 | 0.0% | 81,190 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 3,759 | 0.0% | 83,116 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 4,863 | 0.0% | 95,700 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 4,525 | 0.0% | 95,700 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 2,966 | 0.0% | 90,000 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 5,113 | 0.0% | 80,900 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 3,471 | 0.0% | 80,900 | 3/31/2021 |
| 2020 Q4 | 2/3/2021 | 4,896 | 0.0% | 85,600 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 2,905 | 0.0% | 96,300 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 3,145 | 0.0% | 96,300 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 5,205 | 0.0% | 194,305 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 2,211 | 0.0% | 72,200 | 12/31/2019 |